| Date | Form | Description | Docs | XBRL | Pages |
| 02/10/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
4 | |
| 12/14/10 | 8-K | Current report filing |
|
2 | |
| 12/10/10 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/10/10 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/29/10 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
3 | |
| 09/28/10 | UPLOAD | SEC-generated letter |
|
2 | |
| 09/27/10 | DEF 14A | Definitive proxy statements |
|
21 | |
| 09/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 09/14/10 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
14 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Read More...Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...